Teladoc Health Q3 EPS $(0.35) Beats $(0.37) Estimate, Sales $660.24M Miss $664.11M Estimate
Portfolio Pulse from Benzinga Newsdesk
Teladoc Health reported Q3 losses of $(0.35) per share, beating the analyst consensus estimate of $(0.37) by 5.41%. However, the company's quarterly sales of $660.24 million missed the analyst consensus estimate of $664.11 million by 0.58%.
October 24, 2023 | 8:10 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Teladoc Health's Q3 earnings beat estimates but sales missed, which could lead to mixed market reactions.
Teladoc Health's Q3 earnings beat estimates, which is positive for the stock. However, the company missed sales estimates, which is negative. These mixed results could lead to uncertain market reactions in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100